Angiopoietin-like proteins 8 knockout reduces intermittent hypoxia-induced vascular remodeling in a murine model of obstructive sleep apnea
Yun-yun Yang,Hua-hui Yu,Xiao-lu Jiao,Lin-yi Li,Yun-hui Du,Juan Li,Qian-wen Lv,Hui-na Zhang,Jing Zhang,Chao-wei Hu,Xiao-ping Zhang,Yong-xiang Wei,Yan-wen Qin
DOI: https://doi.org/10.1016/j.bcp.2021.114502
IF: 6.1
2021-04-01
Biochemical Pharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>Obstructive sleep apnea (OSA) is a major risk factor for cardiovascular mortality. Apnea-induced chronic intermittent hypoxia (CIH) is a primary pathophysiological manifestation of OSA that promotes various cardiovascular alterations, such as aortic vascular remodeling. In this study, we investigated the association between angiopoietin-like proteins 8 (ANGPTL8) and CIH-induced aortic vascular remodeling in mice.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>C57BL/6J male mice were divided into four groups: Normoxia group, ANGPTL8<sup>-/-</sup> group, CIH group, CIH+ANGPTL8<sup>-/-</sup> group. Mice in the normoxia group and ANGPTL8<sup>-/-</sup> group received no treatment, while mice in the CIH and CIH+ANGPTL8<sup>-/-</sup> group were subjected to CIH (21%–5% O<sub>2</sub>, 180 s/cycle, 10 h/day) for 6 weeks. At the end of the experiments, intima-media thickness (IMT), elastin disorganization, and aortic wall collagen abundance were assessed <em>in vivo</em>. Immunohistochemistry, Western-blot, and Real time polymerase chain reaction (RT-PCR) were used to detect endoplasmic reticulum stress (ERS) and aortic vascular smooth muscle cell proliferation. ANGPTL8 shRNA and ANGPL8 overexpression were used in aortic vascular smooth muscle cells to investigate the mechanism of ANGPTL8 in CIH.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Compared to the control group, CIH exposure significantly increased intima-media thickness (IMT), elastic fibers disorganization, and aortic wall collagen abundance. CIH also significantly increased blood pressure, induced hyperlipidemia, as well as the expression of ERS protein activating transcription factor-6 (ATF6) and aortic vascular smooth muscle cell proliferation. Contrary, ANGPTL8<sup>-/-</sup> significantly mitigated the CIH-induced vascular remodeling; ANGPTL8<sup>-/-</sup> decreased CIH-induced hypertension and hyperlipidemia, inhibited the protein expression of ATF6, and aortic vascular smooth muscle cell proliferation. Moreover, our <em>in vitro</em> study suggested that CIH could induce ANGPTL8 expression via hypoxia-inducible factor (HIF-1α); ANGPTL8 induced proliferation of aortic vascular smooth muscle cells via the ERS pathway.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>ANGPTL8<sup>-/-</sup> can prevent CIH-induced aortic vascular remodeling, probably through the inhibition of the ERS pathway. Therefore, ANGPTL8 might be a potential target in CIH-induced aortic vascular remodeling.</p>
pharmacology & pharmacy